Postmenopausal women with a history of hormone therapy use have slower biological aging compared to those who never used the ...

Adjuvant cancer treatments such as chemotherapy and radiation are given after a primary cancer treatment to help prevent ...

Company is investing $2.8bn in two Irish plants to produce its in-demand weight loss drugs and a new Alzheimer’s therapy ...

Personalized medicine with individually tailored therapies is becoming more and more a reality in cancer. This requires a ...

Rocket Pharmaceuticals announced enrollment completion for phase 2 study using its gene therapy RP-A501 for treatment of male ...

The decision to use b/tsDMARD monotherapy vs combination therapy with MTX when treating PsA is primarily based on patient satisfaction and drug tolerability.

The Phase III trial compared the efficacy of Fasenra with the standard treatment of GSK’s Nucala in patients with ...

Biological age vs chronological age was younger among postmenopausal female individuals who received hormone replacement therapy.

Stay informed with critical information, news and insights throughout the Boulder Valley and Northern Colorado. AGC Biologics ...

BD announced today that it launched its Neopak XtraFlow glass prefillable syringe and expanded the capacity for the platform.

New biologics such as GSK's Benlysta and AstraZeneca's Saphnelo, along with off-label drugs, have been the mainstay for ...

Alumis, a recent IPO, has ESK-001, a promising phase 3 TYK2 inhibitor for Psoriasis and SLE, showing superior efficacy and safety over existing treatments. ESK-001's allosteric inhibition offers high ...